CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Carevix +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06193590
NCT06193590N/ACompleted

Safety and Efficacy of a Suction Cervical Stabilizer Compared to the Standard Tenaculum for Intrauterine Procedures in the Clinic Setting

Indiana University·interventional·Posted Jan 5, 2024·Updated Jun 10, 2025

In Brief

A clinical study evaluating Carevix and Tenaculum for Intrauterine Device (IUD) and Abnormal Uterine Bleeding. Completed, enrolled 73 participants across 1 site.

Detailed Summary

To evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between intrauterine procedures employing a suction cervical stabilizer (new device, FDA approved, atraumatic) or single-tooth tenaculum (standard, traumatic). This device, cleared by the FDA in 2023, was studied in Europe and showed pain reduced by up to 73% and bleeding reduced by 78% compared to the single-tooth tenaculum for intrauterine contraceptive device insertion. The investigators seek to study this device in the United States, and trial it among all intrauterine procedures.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJan 5, 2024
Enrollment StartNov 9, 2023
Primary CompletionApr 15, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.5 years ago

Interventions

Carevixdevice

Cervical stabilization device that uses vacuum

Tenaculumdevice

standard of care cervical stabilization device